Objectives
To explore the occurrence and characterization of carbapenemaseâproducing pathogens among carbapenemâresistant Gramânegative bacilli isolated from hospitalized patients with urinary tract infection in Indonesia.
Methods
This was a study promoted by the JapaneseâIndonesian collaborative research program in the Japan Initiative for Global Research Network on Infectious Diseases. Bacterial pathogens were prospectively isolated from urine specimens of hospitalized urinary tract infection patients at Dr. Soetomo Hospital (Surabaya, Indonesia). All Gramânegative bacteria resistant to thirdâgeneration cephalosporin or carbapenem were included in this study. Carbapenemase genes were investigated for phenotype and genotype.
Results
In total, 1082 Gramânegative bacilli were isolated, of which 116 strains were resistant to imipenem or meropenem (carbapenemâresistant Gramânegative bacilli), and 22 strains were carbapenemaseâproducing Gramânegative bacilli. Carbapenemaseâproducing Gramânegative bacilli consisted of Acinetobacter baumannii (n = 4), Pseudomonas aeruginosa (n = 4), Klebsiella pneumoniae (n = 5), Providencia rettgeri (n = 4) and five others. The carbapenemaseâproducing Gramânegative bacilli included NDMâ1 (n = 18, 81.8%, in Enterobacteriaceae and Acinetobacter spp.) and IMPâ7 (n = 4, 18.2%, all in P. aeruginosa). Among carbapenemâresistant Gramânegative bacilli, all four P. aeruginosa were sensitive to colistin, and all six Acinetobacter spp. were sensitive to minocycline, colistin and tigecycline. Of those patients harboring carbapenemaseâproducing Gramânegative bacilli, 12 (54.5%) were seriously ill at the time of admission, with longer hospital stays and three deaths (13.6% mortality rate).
Conclusions
Urinary tract infectionâcausing carbapenemâresistant Gramânegative bacilli are widely disseminated in Indonesia. The NDMâ1 phenotype seems to be dominant, and it can be treated with colistin and tigecycline in most cases. Most patients harboring carbapenemaseâproducing Gramânegative bacilli are seriously ill, have a bad prognosis, with a longer hospital stay and a significant mortality rate.